Empowered Funds’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,469
Closed -$555K 2141
2025
Q4
$555K Sell
5,469
-196
-3% -$15.7K 0.01% 732
2025
Q3
$310K Buy
5,665
+1,292
+30% +$64.6K ﹤0.01% 1583
2025
Q2
$232K Buy
+4,373
New +$222K ﹤0.01% 1601
2024
Q1
Sell
-24,403
Closed -$1.81M 1395
2023
Q4
$1.81M Buy
24,403
+743
+3% +$48.7K 0.05% 551
2023
Q3
$1.61M Buy
23,660
+13,922
+143% +$1.18M 0.05% 512
2023
Q2
$914K Buy
+9,738
New +$760K 0.03% 630
2019
Q2
Sell
-15,612
Closed -$1.35M 103
2019
Q1
$1.35M Buy
+15,612
New +$1.33M 0.48% 86

Other funds holding EXAS

Empowered Funds's EXAS Position: Q1 2026 in Review

Empowered Funds sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 5,469 shares — an estimated $555K sold.

Empowered Funds first reported a position in EXAS in Q1 2019 and held it in 7 quarters. The position peaked at $1.81M in Q4 2023. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Empowered Funds reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Empowered Funds sold 5,469 Exact Sciences shares in Q1 2026, an estimated $555K.
  • Empowered Funds first reported a position in Exact Sciences in Q1 2019 and held it in 7 quarters.
  • Empowered Funds's Exact Sciences position peaked at $1.81M in Q4 2023.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.